Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

References for PMC Articles for PubMed (Select 11711405)

1.
2.
3.

Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon: A meta-analysis of randomized trials.

Cummings KJ, Lee SM, West ES, Cid-Ruzafa J, Fein SG, Aoki Y, Sulkowski MS, Goodman SN.

JAMA. 2001 Jan 10;285(2):193-9. Review.

PMID:
11176813
4.

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 update.

Thévenot T, Regimbeau C, Ratziu V, Leroy V, Opolon P, Poynard T.

J Viral Hepat. 2001 Jan;8(1):48-62.

PMID:
11155152
5.
6.

Peginterferon alfa-2a in patients with chronic hepatitis C.

Zeuzem S, Feinman SV, Rasenack J, Heathcote EJ, Lai MY, Gane E, O'Grady J, Reichen J, Diago M, Lin A, Hoffman J, Brunda MJ.

N Engl J Med. 2000 Dec 7;343(23):1666-72.

7.

Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C.

Poynard T, McHutchison J, Davis GL, Esteban-Mur R, Goodman Z, Bedossa P, Albrecht J.

Hepatology. 2000 Nov;32(5):1131-7.

PMID:
11050066
8.

Triple antiviral therapy as a new option for patients with interferon nonresponsive chronic hepatitis C.

Brillanti S, Levantesi F, Masi L, Foli M, Bolondi L.

Hepatology. 2000 Sep;32(3):630-4.

PMID:
10960460
9.

Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: a 20-year multicenter study.

Wiese M, Berr F, Lafrenz M, Porst H, Oesen U.

Hepatology. 2000 Jul;32(1):91-6.

PMID:
10869294
10.

Decisions, decisions, decisions.

Koretz RL.

Gastroenterology. 2000 Jun;118(6):1268-70. No abstract available.

PMID:
10833503
11.

Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy.

Shiratori Y, Imazeki F, Moriyama M, Yano M, Arakawa Y, Yokosuka O, Kuroki T, Nishiguchi S, Sata M, Yamada G, Fujiyama S, Yoshida H, Omata M.

Ann Intern Med. 2000 Apr 4;132(7):517-24.

PMID:
10744587
12.

45-year follow-up of hepatitis C virus infection in healthy young adults.

Seeff LB, Miller RN, Rabkin CS, Buskell-Bales Z, Straley-Eason KD, Smoak BL, Johnson LD, Lee SR, Kaplan EL.

Ann Intern Med. 2000 Jan 18;132(2):105-11.

PMID:
10644270
13.

Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral Hepatitis.

Schalm SW, Weiland O, Hansen BE, Milella M, Lai MY, Hollander A, Michielsen PP, Bellobuono A, Chemello L, Pastore G, Chen DS, Brouwer JT.

Gastroenterology. 1999 Aug;117(2):408-13.

PMID:
10419923
14.
15.

Natural history of chronic hepatitis C.

Pagliaro L, Peri V, Linea C, Cammà C, Giunta M, Magrin S.

Ital J Gastroenterol Hepatol. 1999 Jan-Feb;31(1):28-44. Review.

PMID:
10091101
16.

Is antiviral treatment (IFN alpha and/or ribavirin) justified in cirrhosis related to hepatitis C virus? Société Royale Belge de Gastro-entérologie.

Poynard T, Moussalli J, Ratziu V, Thevenot T, Regimbeau C, Opolon P, Horsmans Y, Brenard R, Closon M, Fevery J, Hautekeete M.

Acta Gastroenterol Belg. 1998 Oct-Dec;61(4):431-7. Review.

PMID:
9923094
17.

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.

Davis GL, Esteban-Mur R, Rustgi V, Hoefs J, Gordon SC, Trepo C, Shiffman ML, Zeuzem S, Craxi A, Ling MH, Albrecht J.

N Engl J Med. 1998 Nov 19;339(21):1493-9.

18.

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.

McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK.

N Engl J Med. 1998 Nov 19;339(21):1485-92.

19.
20.

Interferon in wonderland.

Koretz RL.

Gastroenterology. 1998 Oct;115(4):1027-9. No abstract available.

PMID:
9786731
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk